Although the functional interaction between Rcn3 and PCSK6 remains to be fully elucidated, these observations raise the possibility that post-infarction proteolytic processing of Rcn3 may influence its anti-fibrotic activity, warranting further investigation. This evidence concerns the gene PCSK6 and infarction.